← Dashboard
Stock
CYTOF
Altamira Therapeutics Ltd.0 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
0
27 funds tracked
Ever held
1
Current + past
New this quarter
0
Exited this quarter
0
Marquee-fund ownership over time
Nov 14, 2024Feb 14, 2025
Now
0
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors | Q4 2024 | Q1 2025 | — | +0% |
Fundamentals
XBRL · Altamira Therapeutics Ltd.Not enough XBRL history to plot. Altamira Therapeutics Ltd.hasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Altamira Therapeutics Ltd. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KREPORT OF FOREIGN PRIVATE ISSUERAug 29, 2025
- 6-KFORM 6-KJun 11, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 9, 2025
- 20-FANNUAL REPORTApr 30, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 30, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 10, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERDec 20, 2024
- SC 13G5%+ ownership (passive)Nov 14, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUEROct 4, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERSep 24, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERSep 19, 2024
- 20-F/AAMENDMENT NO. 2 TO FORM 20-FJul 1, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 16, 2024
- 20-F/AAMENDMENT NO. 1 TO FORM 20-FApr 22, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 16, 2024
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q4 2024 | Q1 2025 | $0.00 | — | +0% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.